Group One Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3630 |
|
|
2023
Q2 | – | Sell |
-24,376
| Closed | -$2.22M | – | 3595 |
|
|
2023
Q1 | $2.22M | Buy |
24,376
+4,802
| +25% | +$437K | 0.01% | 182 |
|
|
2022
Q4 | $744K | Buy |
+19,574
| New | +$744K | ﹤0.01% | 443 |
|
|
2022
Q3 | – | Sell |
-17,725
| Closed | -$539K | – | 3518 |
|
|
2022
Q2 | $539K | Buy |
+17,725
| New | +$539K | ﹤0.01% | 594 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3543 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3538 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3458 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3296 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3096 |
|
|
2020
Q4 | – | Sell |
-6,015
| Closed | -$586K | – | 2802 |
|
|
2020
Q3 | $586K | Buy |
+6,015
| New | +$586K | ﹤0.01% | 495 |
|
|
2020
Q2 | – | Sell |
-146
| Closed | -$21K | – | 2473 |
|
|
2020
Q1 | $21K | Sell |
146
-1,667
| -92% | -$240K | ﹤0.01% | 985 |
|
|
2019
Q4 | $371K | Buy |
1,813
+1,544
| +574% | +$316K | ﹤0.01% | 493 |
|
|
2019
Q3 | $22K | Sell |
269
-169
| -39% | -$13.8K | ﹤0.01% | 1001 |
|
|
2019
Q2 | $41K | Hold |
438
| – | – | ﹤0.01% | 854 |
|
|
2019
Q1 | $37K | Buy |
+438
| New | +$37K | ﹤0.01% | 804 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2220 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2224 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$2K | – | 2148 |
|
|
2018
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1228 |
|